PMID- 30367996 OWN - NLM STAT- MEDLINE DCOM- 20200217 LR - 20200217 IS - 1873-4596 (Electronic) IS - 0891-5849 (Linking) VI - 130 DP - 2019 Jan TI - Soluble receptor for advance glycation end-products inhibits ischemia/reperfusion-induced myocardial autophagy via the STAT3 pathway. PG - 107-119 LID - S0891-5849(18)31365-0 [pii] LID - 10.1016/j.freeradbiomed.2018.10.437 [doi] AB - The pathogenesis of myocardial ischemia/reperfusion (I/R) is poorly understood, but recent evidence suggests that autophagy plays crucial roles in I/R injuries. Soluble receptor for advanced glycation end-products (sRAGE) exerts protective effects during I/R by decreasing cardiac apoptosis, which is mediated via increasing the ubiquitin proteasome system (UPS) and signal transducer and activator of transcription 3 (STAT3). The present study examined the effects and mechanisms of sRAGE on I/R-triggered cardiac autophagy. I/R was performed in mice or primary neonatal cardiomyocytes with or without sRAGE administration or overexpression. Cardiac function and infarct size were detected in mouse hearts. Apoptosis, autophagy and autophagy-related signaling pathways were detected in mouse hearts and cardiomyocytes. The results demonstrated that sRAGE significantly improved cardiac function and reduced infarct size during I/R in mice. sRAGE inhibited I/R-induced apoptosis, which correlated with a reduction in autophagy-associated proteins, including ATG7, Beclin-1 and microtubule-associated protein 1 light chain 3 (LC3). sRAGE reduced autophagosome formation during I/R in vivo and in vitro. sRAGE significantly activated STAT3, but not mammalian target of rapamycin (mTOR), during I/R in vivo and in vitro, and suppression of STAT3 abolished the sRAGE inhibition of autophagy during I/R in vitro. Activation of autophagy using ATG7 overexpression with an adenovirus significantly abolished the sRAGE-induced reduction of cardiac apoptosis during I/R. These results suggest that sRAGE inhibits I/R injuries in the heart via a decrease in autophagy, a process that is dependent on STAT3 activation. CI - Copyright (c) 2018 Elsevier Inc. All rights reserved. FAU - Dang, Mengqiu AU - Dang M AD - Department of Cardiology, Beijing Tian Tan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China. FAU - Zeng, Xiangjun AU - Zeng X AD - Department of Physiology and Pathophysiology, Capital Medical University, Beijing 100069, China. FAU - Chen, Buxing AU - Chen B AD - Department of Cardiology, Beijing Tian Tan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China. FAU - Wang, Hongxia AU - Wang H AD - Department of Physiology and Pathophysiology, Capital Medical University, Beijing 100069, China. FAU - Li, Huihua AU - Li H AD - Department of Cardiology, Institute of cardiovascular Disease, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China; Department of Nutrition and Food Hygiene, School of Public Health, Advanced Institute of Medical Sciences, Dalian Medical University, Dalian 116044, China. FAU - Liu, Yu AU - Liu Y AD - Department of Physiology and Pathophysiology, Capital Medical University, Beijing 100069, China. FAU - Zhang, Xiuling AU - Zhang X AD - Department of Cardiology, Beijing Tian Tan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China. FAU - Cao, Xianxian AU - Cao X AD - Department of Cardiology, Beijing Tian Tan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China. FAU - Du, Fenghe AU - Du F AD - Department of Cardiology, Beijing Tian Tan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China; Department of Geriatrics, Beijing Tian Tan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China. FAU - Guo, Caixia AU - Guo C AD - Department of Cardiology, Beijing Tian Tan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China. Electronic address: cxguo@ccmu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20181025 PL - United States TA - Free Radic Biol Med JT - Free radical biology & medicine JID - 8709159 RN - 0 (Glycation End Products, Advanced) RN - 0 (Receptor for Advanced Glycation End Products) RN - 0 (STAT3 Transcription Factor) RN - EC 6.2.1.45 (Autophagy-Related Protein 7) SB - IM MH - Animals MH - Autophagy MH - Autophagy-Related Protein 7/genetics/metabolism MH - Cells, Cultured MH - Glycation End Products, Advanced/*metabolism MH - Humans MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Myocardium/*metabolism MH - Myocytes, Cardiac/*physiology MH - Receptor for Advanced Glycation End Products/*metabolism MH - Reperfusion Injury/*metabolism MH - STAT3 Transcription Factor/metabolism MH - Signal Transduction OTO - NOTNLM OT - Autophagy OT - I/R OT - Myocardium OT - SRAGE OT - STAT3 EDAT- 2018/10/28 06:00 MHDA- 2020/02/18 06:00 CRDT- 2018/10/28 06:00 PHST- 2018/08/06 00:00 [received] PHST- 2018/10/20 00:00 [revised] PHST- 2018/10/22 00:00 [accepted] PHST- 2018/10/28 06:00 [pubmed] PHST- 2020/02/18 06:00 [medline] PHST- 2018/10/28 06:00 [entrez] AID - S0891-5849(18)31365-0 [pii] AID - 10.1016/j.freeradbiomed.2018.10.437 [doi] PST - ppublish SO - Free Radic Biol Med. 2019 Jan;130:107-119. doi: 10.1016/j.freeradbiomed.2018.10.437. Epub 2018 Oct 25.